Generation of a PPM1A-deficient human induced pluripotent stem cell line using CRISPR-Cas9 technology

Xinrui Guo1, Kui Zhao2, Yanqi Zhang3

  • 1Shandong Medicinal Biotechnology Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250012, China.

Stem Cell Research
|April 21, 2024
PubMed

Insights

Researchers created a knockout human induced pluripotent stem cell (hiPSC) line for PPM1A, a key regulator of cell functions. This new cell line is a valuable tool for studying PPM1A

Area of Science:

  • Molecular Biology
  • Stem Cell Biology
  • Biochemistry

Background:

  • Protein phosphatase PPM1A regulates critical cellular processes including growth, stress response, immunity, and tumor formation.
  • Understanding PPM1A's role requires specific cellular models to investigate its regulatory mechanisms.

Purpose of the Study:

  • To generate a human induced pluripotent stem cell (hiPSC) line lacking functional PPM1A using CRISPR/Cas9 technology.
  • To validate the pluripotency and differentiation capacity of the generated PPM1A-knockout hiPSC line.
  • To establish a cellular resource for investigating PPM1A's downstream signaling and therapeutic potential.

Main Methods:

  • CRISPR/Cas9-mediated gene targeting was employed to knockout the PPM1A gene in hiPSCs.
  • Standard stem cell characterization techniques were used, including karyotyping, pluripotency marker assessment, and trilineage differentiation assays.

Main Results:

  • A stable hiPSC line with PPM1A knockout was successfully generated.
  • The resulting cell line maintained a normal karyotype and exhibited robust pluripotency.
  • Confirmed trilineage differentiation potential (ectoderm, mesoderm, endoderm) in the PPM1A-knockout hiPSCs.

Conclusions:

  • The PPM1A-knockout hiPSC line is a well-characterized and viable cellular model.
  • This resource facilitates research into PPM1A's function in signaling pathways and its role in diseases.
  • Potential applications include exploring PPM1A in anti-tumor and anti-infection strategies.